Inventor · disambiguated record
Agnes Gouble
Also filed as: GOUBLE AGNES · GOUBLE AGNÈS
13 granted patents·20 pending applications·109 citations·filing 2004–2023
92Inventor score
Files withCELLECTIS23ARNOULD SYLVAIN5CELLECTIS SA1CENTRO DE INVESTIG BIOMEDICA EN RED CIBER1GOUBLE AGNES1
Top patents by PatentIndex Score
33 records- 0195US10286007B2Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cellsCELLECTIS·Filed 2017·Granted May 14, 2019·12 cites·18 claims
- 0295US7842489B2Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofCELLECTIS·Filed 2010·Granted Nov 30, 2010·63 cites·7 claims
- 0394US11274316B2Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cellsCELLECTIS·Filed 2021·Granted Mar 15, 2022·2 cites·5 claims
- 0491US10363270B2Methods for engineering allogeneic and immunosuppressive resistant T cell immunotherapyCELLECTIS·Filed 2017·Granted Jul 30, 2019·6 cites·7 claims
- 0590US10426795B2Use of preTalpha or functional variant thereof for expanding TCRalpha deficient T cellsCELLECTIS·Filed 2013·Granted Oct 1, 2019·8 cites·17 claims
- 0689US2024309397A1Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapyCELLECTIS·Filed 2023·Application pending·0 cites
- 0787US11304975B2Methods for engineering allogeneic and highly active t cell for immunotherapyCELLECTIS·Filed 2014·Granted Apr 19, 2022·4 cites·6 claims
- 0886US11891614B2Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapyCELLECTIS·Filed 2020·Granted Feb 6, 2024·1 cites·16 claims
- 0986US10517896B2Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cellsCELLECTIS·Filed 2019·Granted Dec 31, 2019·2 cites·19 claims
- 1084US8426177B2Meganuclease variants cleaving a DNA target sequence from the mouse ROSA26 locus and uses thereofGOUBLE AGNES·Filed 2008·Granted Apr 23, 2013·10 cites·1 claims
- 1182US2022177914A1Use of pre t alpha or functional variant thereof for expanding tcr alpha deficient t cellsCELLECTIS·Filed 2022·Application pending·0 cites
- 1279US11414674B2Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cellsCELLECTIS·Filed 2019·Granted Aug 16, 2022·0 cites·10 claims
- 1377US11311575B2Methods for engineering highly active T cell for immunotherapyCELLECTIS·Filed 2014·Granted Apr 26, 2022·1 cites·15 claims
- 1472US11603539B2Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapyCELLECTIS·Filed 2013·Granted Mar 14, 2023·0 cites·9 claims
- 1570US2023201260A1Methods for engineering allogeneic and highly active t cell for immunotheraphyCELLECTIS·Filed 2022·Application pending·0 cites
- 1670US2018360883A1Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapyCELLECTIS·Filed 2018·Application pending·0 cites
- 1767US2023050345A1Methods for engineering allogeneic and highly active t cell for immunotheraphyCELLECTIS·Filed 2022·Application pending·0 cites
- 1862US2014121115A1Custom-made meganuclease and use thereofARNOULD SYLVAIN·Filed 2012·Application pending·0 cites
- 1961US2016273003A1Use of meganucelases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofCELLECTIS SA·Filed 2016·Application pending·0 cites
- 2060US2023056268A1Methods for engineering highly active t cell for immunotheraphyCELLECTIS·Filed 2022·Application pending·0 cites
- 2158US2011151539A1Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2011·Application pending·0 cites
- 2257US2012159659A1Custom-made meganuclease and use thereofARNOULD SYLVAIN·Filed 2010·Application pending·0 cites
- 2357US2006153826A1Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2004·Application pending·0 cites
- 2457US2006206949A1Custom-made meganuclease and use thereofARNOULD SYLVAIN·Filed 2004·Application pending·0 cites
- 2557US2011091441A1Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereofCELLECTIS·Filed 2008·Application pending·0 cites
- 2655US2010146651A1Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereofCELLECTIS·Filed 2007·Application pending·0 cites
- 2754US2013236946A1Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereofCELLECTIS·Filed 2013·Application pending·0 cites
- 2851US2014017731A1Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereofCELLECTIS·Filed 2013·Application pending·0 cites
- 2950US2015017136A1Methods for engineering allogeneic and highly active t cell for immunotherapyCELLECTIS·Filed 2013·Application pending·0 cites
- 3048US11767512B2Sequence specific reagents targeting CCR5 in primary hematopoietic cellsCELLECTIS·Filed 2018·Granted Sep 26, 2023·0 cites·24 claims
- 3144US2013059387A1Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereofSMITH JULIANNE·Filed 2012·Application pending·0 cites
- 3241US2014112904A9Method for enhancing the cleavage activity of i-crei derived meganucleasesGRIZOT SYLVESTRE·Filed 2008·Application pending·0 cites
- 3329US2018320138A1Process of gene-editing of cells isolated from a subject suffering from a metabolic disease affecting the erythroid lineage, cells obtained by said process and uses thereofCENTRO DE INVESTIG BIOMEDICA EN RED CIBER·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Agnes Gouble files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →